Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
41.40 45.87 35.52 39.49 50.55 57.39 37.69 16.52 57.84 27.08
Piotroski F-Score
5 6 7 6 8 3 5 3 5 7
P/S ratio
5.35 6.07 5.49 5.04 5.89 6.41 5.28 4.31 4.75 3.95
Altman Z-Score
4.81 5.30 4.76 4.18 4.54 3.90 4.31 3.85 4.56 4.26
Altman Z″-Score (non-manufacturers)
3.96 4.06 3.70 3.39 3.60 3.16 4.10 3.90 4.21 4.56
P/FCF ratio
31.36 39.34 35.86 45.70 36.82 32.98 50.92 28.77 61.45 31.35
Beneish M-Score
(2.62) (2.57) (2.50) (2.32) (2.54) (2.72) (2.28) (2.28) (2.45) (2.34)
P/Operating CF
62.68 71.04 73.59 92.77 100.82 74.38 106.83 56.06 86.97 67.90
Dividend Safety Score
82 — — — — — — — — —
P/B ratio
5.99 6.65 6.05 5.60 6.78 7.03 6.13 5.00 5.92 4.68
Price to Tangible BV
0.00 357.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
5.82 6.47 5.97 5.65 6.45 7.18 5.72 4.76 5.10 4.26
EV/EBITDA
24.02 30.87 24.90 27.13 30.86 33.93 24.40 19.88 21.60 17.72
EV/Operating CF
28.96 34.48 32.98 39.70 33.80 31.42 38.88 24.83 40.72 25.17
EV/FCF
34.11 41.95 39.03 51.16 40.28 36.91 55.24 31.80 66.06 33.83
Quick Ratio
1.04 1.11 0.86 0.87 1.33 1.14 1.66 1.25 1.43 1.70
Current Ratio
1.89 1.95 1.58 1.63 2.20 1.93 2.51 2.02 2.29 2.50
Net Debt/EBITDA
1.93 1.92 2.02 2.90 2.65 3.61 1.91 1.89 1.51 1.30
Debt/Assets
33.15% 31.64% 32.56% 35.38% 36.03% 40.75% 36.76% 36.21% 32.54% 33.83%
Debt/Equity
0.71 0.66 0.70 0.79 0.84 1.07 0.87 0.84 0.72 0.72
Asset Turnover
0.55 0.55 0.53 0.52 0.50 0.45 0.52 0.55 0.58 0.62
Operating CF/Net income
1.55 1.42 1.17 1.11 1.64 2.05 1.05 0.73 1.53 1.16
Capex/Depreciation
(0.64) (0.72) (0.56) (0.59) (0.53) (0.60) (0.83) (0.79) (0.93) (0.90)
Interest Coverage
8.05 9.02 10.71 30.22 38.00 21.79 17.50 21.32 38.28 75.00
ROE
15.08% 15.26% 17.98% 14.97% 14.26% 12.35% 16.98% 32.73% 10.45% 18.24%
ROA
7.15% 7.22% 8.24% 6.59% 5.78% 4.96% 7.26% 14.38% 4.79% 8.99%
ROIC
8.94% 7.75% 8.52% 6.40% 6.64% 5.78% 8.71% 8.86% 9.96% 10.39%
Return on Tangible Assets
29.95% 28.03% 40.51% 33.97% 24.02% 21.56% 22.58% 49.23% 15.73% 26.22%
Average Days of Receivables
58.70 64.41 67.04 70.53 64.47 68.70 70.95 62.58 64.47 63.40
Research and Development Expense of Revenue
6.46% 6.49% 6.77% 7.88% 7.22% 6.86% 6.52% 6.34% 6.32% 6.31%
Selling, General and Administrative Expense of Revenue
34.44% 34.01% 34.69% 34.61% 37.57% 37.36% 35.98% 37.49% 36.58% 36.53%
Intangible Assets out of Total Assets
0.52 0.47 0.50 0.54 0.51 0.53 0.44 0.47 0.48 0.48
Share Based Compensation of Revenue
0.97% 1.01% 1.00% 0.91% 1.00% 0.99% 0.85% 0.87% 0.91% 0.86%
Graham Net Nets
(0.08) (0.05) (0.08) (0.11) (0.10) (0.13) (0.08) (0.10) (0.07) (0.07)
Graham Number
105.86 97.80 95.87 78.48 68.53 57.86 65.51 81.82 40.49 50.33
Earnings Yield
2.42% 2.18% 2.82% 2.53% 1.98% 1.74% 2.65% 6.05% 1.73% 3.69%
Free Cash Flow Yield
3.19% 2.54% 2.79% 2.19% 2.72% 3.03% 1.96% 3.48% 1.63% 3.19%
Revenue per Share
65.71 59.30 54.00 48.78 45.38 38.22 39.80 36.36 33.27 30.27
Operating CF per Share
13.20 11.13 9.78 6.94 8.66 8.73 5.86 6.98 4.17 5.12
Capex per Share
(1.99) (1.98) (1.51) (1.55) (1.39) (1.30) (1.74) (1.53) (1.60) (1.31)
Free Cash Flow per Share
11.21 9.15 8.26 5.38 7.26 7.43 4.12 5.45 2.57 3.81
Cash per Share
10.73 11.79 8.04 5.10 8.01 8.05 11.83 9.89 7.47 9.05
Shareholders Equity per Share
58.66 54.16 48.98 43.93 39.46 34.84 34.24 31.36 26.68 25.53
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
58.66 54.16 48.98 43.93 39.46 34.84 34.24 31.36 26.68 25.53
Free Cash Flow
4,283.00 3,487.00 3,136.00 2,036.00 2,738.00 2,790.00 1,542.00 2,038.00 961.00 1,425.00
Working Capital
6,961.00 7,231.00 4,597.00 3,972.00 5,468.00 4,666.00 6,658.00 4,926.00 4,508.00 4,713.00
Capital Expenditures
(761.00) (755.00) (575.00) (588.00) (525.00) (487.00) (649.00) (572.00) (598.00) (490.00)
Net Current Asset Value
(10,669.00) (7,490.00) (8,801.00) (9,993.00) (9,737.00) (11,539.00) (6,302.00) (5,766.00) (4,224.00) (3,024.00)
EV/EBIT
29.88 39.65 31.48 36.67 42.68 46.32 31.40 25.54 27.64 22.16
Capex to Sales
0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.05 0.04
Price to Operating Income
27.48 37.19 28.92 32.75 39.02 41.39 28.94 23.11 25.71 20.54
Other line items
Depreciation/Fixed assets
0.31 0.30 0.32 0.34 0.35 0.30 0.30 0.32 0.33 0.35
Cash ROIC
10.11% 9.00% 9.05% 6.44% 9.01% 9.27% 5.44% 8.06% 4.81% 7.18%
Accounts Receivable Turnover
6.26 5.83 5.59 5.60 5.98 5.13 5.70 6.00 5.98 6.24
Accounts Payable Turnover
5.20 5.10 5.08 5.41 6.33 7.13 7.85 8.23 9.23 9.02
Inventory Turnover
1.80 1.70 1.68 1.88 1.80 1.64 1.75 1.72 1.90 2.08
Average Days of Payables
72.55 75.15 74.42 75.06 67.11 55.85 47.49 50.57 41.69 41.74
Days of Inventory on Hand
214.14 213.67 237.59 212.22 197.00 240.90 209.66 231.31 211.00 193.92
Average Receivables
4,013.00 3,876.00 3,665.00 3,293.50 2,861.50 2,797.00 2,612.50 2,265.00 2,082.50 1,814.50
Average Payables
1,739.00 1,598.00 1,465.00 1,271.00 969.50 742.50 660.50 566.50 462.00 423.50
Average Inventory
5,042.00 4,808.50 4,419.00 3,654.50 3,404.00 3,237.00 2,967.50 2,710.00 2,247.50 1,834.50
Average Assets
45,407.50 41,441.50 38,398.00 35,757.50 34,480.50 32,248.50 28,698.00 24,713.00 21,316.00 18,329.00
Average Common Equity
21,527.00 19,613.50 17,604.50 15,746.50 13,980.50 12,945.50 12,268.50 10,855.00 9,765.00 9,030.50

Fold the line items

Columns are period end dates